Very good news to hear for the start of the week! Commencement of phase 2 trials into epilepsy and planning for commencement of phase 2 trial into MS spasticity treatment. This is a long term play over the next 12 months with this being a major catalyst if successful.
"We look forward to providing our shareholders with updates on the progress of our Phase 2 clinical trial, along with further operational from our Duncan Facility in Canada, as we ramp up production over the coming months."
Very good news to hear for the start of the week! Commencement...
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
